Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Your concentration becomes 7.5 mg/mL instead of 10 mg/mL
This maximum-potency mass is specifically tailored for laboratories establishing extensive dose-dependent formulation matrices, analyzing vehicle viscosity interactions, and mapping long-term structural gene expression modulations across high-throughput screening assays
A recent systematic review also identified 33 registered clinical trials examining GLP-1s for substance use disorders, with growing interest in opioid and stimulant dependencies
Canada Europe Germany UK France Spain Italy Switzerland Rest of Europe Asia Pacific China Japan India Australia South Korea Rest of Asia Pacific Latin America Brazil Mexico Rest of Latin America Middle East & Africa South Africa Saudi Arabia Rest of Middle East & Africa Table of Contents Chapter 1 Methodology & Scope Chapter 2 Executive Summary Chapter 3 Industry Insights Chapter 4 Competitive Landscape, 2022 Chapter 5 Market Estimates and Forecast, By Drug Class (USD Million) Chapter 6 Market Estimates and Forecast, By Route of Administration (USD Million) Chapter 7 Market Estimates and Forecast, By Application (USD Million) Chapter 8 Market Estimates and Forecast, By Distribution Channel (USD Million) Chapter 9 Market Estimates and Forecast, By Region (USD Million) Chapter 10 Company Profiles Don't see your key competitors
